Infrastructure and Methods to Support Real Time Biosurveillance Kenneth D. Mandl, MD, MPH Children’s Hospital Boston Harvard Medical School.

Slides:



Advertisements
Similar presentations
Copyright 2004 Northrop Grumman Corporation 0 HIT Summit Leveraging HIT for Public Health Surveillance HIT Summit Leveraging HIT for Public Health Surveillance.
Advertisements

Responding to the Threat of Bioterrorism: A Status Report on Vaccine Research in the United States Good Morning. Over the next 1 ½ hours of so I’ll be.
Statistical Issues and Challenges Associated with Rapid Detection of Bio-Terrorist Attacks SE Fienberg and G Shmueli (2005) Presented by Lisa Denogean.
For Official Use Only. Public Health and EMS How Long Do You Have to Live? For Official Use Only.
NYC Syndromic Surveillance IFH HIT Meaningful Use Workshop 10/1/2010 Marlena Plagianos, MS NYCDOHMH
Comparability of Electronic and Manual Influenza-like Illness (ILI) Surveillance Methods Robin M. Williams, Nebraska Department of Health & Human Services/University.
Capability Cliff Notes Series PHEP Capability 13—Public Health Surveillance and Epidemiological Investigation What Is It And How Will We Measure It?
Disease surveillance is an epidemiological practice by which.
Placing Bioterrorism in its Context Dr. C. de Ville de Goyet.
United States Department of Agriculture Food Safety Inspection Service LCDR Kimberly Elenberg, HHSD Consumer Complaint Monitoring System.
Overview of Uses for Public Health Surveillance Daniel M. Sosin, M.D., M.P.H. Division of Public Health Surveillance and Informatics Epidemiology Program.
1 Bioterrorism Presentation Sharon F. Grigsby, MBA Executive Director Bioterrorism Preparedness Program Public Health Department of Health Services County.
From Data to Signals to Screenshots: Recent Developments in NYCDOHMH ED Syndromic Surveillance. Marc Paladini New York City Department of Health and Mental.
Moderator: Kenneth L Stewart – Angelo State University Panelists – Annette Sobel – Texas Tech University Health Sciences Center Billy U. Philips, Jr. –
UNCLASSIFIED Building Biosurveillance Systems for Early Detection of Public Health Events Central Asia Regional Health Security Conference April.
U.S. Surveillance Update Anthony Fiore, MD, MPH CAPT, USPHS Influenza Division National Center for Immunizations and Respiratory Disease Centers for Disease.
 2004 University of Pittsburgh Bayesian Biosurveillance Using Multiple Data Streams Weng-Keen Wong, Greg Cooper, Denver Dash *, John Levander, John Dowling,
Implementing a Syndromic Surveillance System in Miami-Dade County Fermin Leguen, MD, MPH Chief Physician Director, Office of Epidemiology & Disease Control.
Overview of Terrorism Research at the CDC Dixie E. Snider, M.D., MPH. Associate Director for Science Presented at 2003 Medical Research Summit March 6,
Syndromic Surveillance in Georgia: A Grassroots Approach February 22, 2006 Erin L. Murray Karl Soetebier Georgia Division of Public Health.
Overview of ‘Syndromic Surveillance’ presented as background to Multiple Data Source Issue for DIMACS Working Group on Adverse Event/Disease Reporting,
August 12, Meaningful Use *** UDOH Informatics Brown Bag Robert T Rolfs, MD, MPH.
Aaron Fleischauer, PhD, MPH
Bioterrorism MLAB 2434: Microiology Keri Brophy-Martinez.
Influenza Surveillance at IRID Immunization and Respiratory Infections Division Centre for Infectious Disease Prevention & Control Public Health Agency.
Disease Surveillance in NYS Jim Miller, MD, MPH Director, Bioterrorism Epidemiology New York State Department of Health
Health Care for the Homeless Training Hawaii Primary Care Association June 27, 2013 Brenda Goldstein, MPH
Ebola Virus Disease Clinical manifestations Ebola Virus Disease Clinical manifestations N. Shindo Lead, Clinical & Infection Control Pandemic & Epidemic.
1 Get Ready to RHIO Health Information Exchanges and Emergency Preparedness Jeff Odell, Senior Vice President MedVirginia x227
Local Emergency Response to Biohazardous Incidents Dr. Elizabeth Whalen, MD Medical Director Albany County Health Department April 8, 2005 Northeast Biological.
Additional Data For Harmonized Use Case for Biosurveillance HINF 5430 Final Project By Maria Metty, Priyaranjan Tokachichu &Resty Namata December 13, 2007.
Lauren Lewis, MD, MPH Health Studies Branch Environmental Hazards and Health Effects National Center for Environmental Health Centers for Disease Control.
Surveillance Overview Julia Gunn Boston Public Health Commission.
Information Exchange for Detection and Monitoring: Clinical Care to Health Departments Janet J Hamilton, MPH Florida Department of Health.
0 Craig Miller Vice President, Health Strategy and Innovation Health Information Exchange: Facilitating data sharing between public.
Influenza-like Illness Surveillance at the National Level
Novel H1N1 Influenza: Research Needs Julia Gunn Boston Public Health Commission.
1 ESSENCE: Biosurveillance in Support of the DoD Health Mission.
Queen’s University Public Health Informatics (QPHI) Team Occupational Health Surveillance Tara Donovan QPHI Surveillance Meeting Exploring.
Assessing Hospital and Health System Preparedness and Response Nathaniel Hupert, M.D., M.P.H. Assistant Professor of Public Health and Medicine Division.
1 Biological Agents Slides will automatically advance seconds after clicking on start button.
Infectious Disease Epidemiology Surveillance. 9/22/00ANN JOLLY 2 Definition n “Ongoing systematic collection, analysis, and interpretation of health data.
Expect the Unexpected on Campus Sandra Samuels, MD Medical Director, Rutgers University Health Service - Newark.
Harmonized Biosurveillance Use Case By Resty Namata, Maria Metty & Priyaranjan Tokachichu December 13, 2007.
Emergency Department Syndromic Surveillance (EDSS): A public health unit perspective alPHa Meeting Feb 1, 2007.
Project Sentinel Collaboratory Georgetown University Medical Center Washington Hospital Center Seong K. Mun, PhD Funded By National Library of Medicine.
The Delaware Electronic Reporting and Surveillance System (DERSS)
~PPT Howard Burkom 1, PhD Yevgeniy Elbert 2, MSc LTC Julie Pavlin 2, MD MPH Christina Polyak 2, MPH 1 The Johns Hopkins University Applied Physics.
Queen’s University Public Health Informatics (QPHI) Team Can Occupational Health data contribute to Public Health? Tara Donovan Institute.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 24 Public Health Surveillance.
Rational Strategies Interventions of choiceInterventions of choice Economic, social and other non-medical countermeasures Interventions of last resortInterventions.
Diseases in Nature Conference John Herbold DVM, MPH, PhD, DACVPM, FACE Center for Biosecurity & Public Health Preparedness University of Texas School of.
Correlation of National Influenza Surveillance Data to the Local Experience Kate Goodin, MPH Florida Department of Health Bureau of Epidemiology 6 th Annual.
Infectious Disease Surveillance & National/Health Security Michael A. Stoto CNSTAT Workshop on Vital Data for National Needs April 30, 2008, Washington.
Bioterrorism Agents Epidemiology Program Overview.
Syndromic Surveillance and The Health Alert Network Lex Gibson Epidemiologist Alleghany/Roanoke City Health Districts.
Bioterrorism: A Changing World and What You Can Do
Flu Update and Overview of Flu Surveillance in RI
Evaluating the Effectiveness of Using Syndromic Surveillance
APHA, Washington, November, 2007
What is “Syndromic” Surveillance?
Overview of Terrorism Research at the CDC
One Health Early Warning Alert
Influenza-like Illness Surveillance at the National Level
Health Information Exchange Interoperability
Harvard Medical School Center for Biomedical Informatics
Representativeness of Emergency Department Data Reported to the BioSense System Patrick Minor, M.S.P.H., Roseanne English, B.S., Jerome Tokars, M.D, M.P.H.
Presented by: Cynthia Paes, Privacy Officer County of San Diego
Public Health Surveillance
Introduction to public health surveillance
Presentation transcript:

Infrastructure and Methods to Support Real Time Biosurveillance Kenneth D. Mandl, MD, MPH Children’s Hospital Boston Harvard Medical School

Category A agents Anthrax ( Bacillus anthracis ) Botulism ( Clostridium botulinum toxin )» Plague ( Yersinia pestis )» Smallpox ( Variola major )» Tularemia ( Francisella tularensis )» Viral hemorrhagic fevers ( filoviruses [e.g., Ebola, Marburg] and arenaviruses [e.g., Lassa])

Natural history—Anthrax Incubation is 1-6 days Flu like symptoms followed in 2 days by acute phase, including breathing difficulty, shock. Death within 24 hours of acute phase Treatment must be initiated within 24 hours of symptoms

Attack scenario—Anthrax State sponsored terrorist attack Release of Anthrax, NYC subway No notification by perpetrators 1% of the passengers exposed during rush hour will contract the disease

Effective Treatment Period Gain of 2 days Early Detection Traditional Disease Detection Phase II Acute Illness Phase I Initial Symptoms Need for early detection

But... Until now, there has been no real time surveillance for any diseases The threat of bioterrorism has focused interest on and brought funding to this problem

Where can real time information have a beneficial effect? Diagnosis Decision Support Response Coordination Communication Surveillance Detection Monitoring

Surveillance of what? Environment Biological sensors Citizenry Health related behaviors Biological markers Patient populations Patterns of health services use Biological markers

Syndromic surveillance Use patterns of behavior or health care use, for early warning Example, influenza-like illness Really should be called “prodromic surveillance”

Early implementations Drop in surveillance Paper based Computer based (Leaders) Automated surveillance Health care data “Non-traditional” data sources

Syndromes tracked at WTC 2001 Syndromic Surveillance for Bioterrorism Following the Attacks on the World Trade Center --- New York City, MMWR. 2002;51((Special Issue)):13-15.

Health care data sources Patient demographic information Emergency department chief complaints International Classification of Disease (ICD) Text-based notes Laboratory data Radiological reports Physician reports (not automated) ?new processes for data collection?

“Non traditional data sources” Pharmacy data 911 operators Call triage centers School absenteeism Animal surveillance Agricultural data

Data Integration Technical challenges Security issues Political barriers Privacy concerns

Data Issues Data often collected for other purposes Data formats are nonstandard Data may not be available in a timely fashion Syndrome definitions may be problematic

Data quality Data often collected for other purposes What do the data represent? Who is entering them? When are they entered? How are they entered? Electronic vs. paper

Measured quality/value of data

Data standards Health care data standards have been elusive HL7 LOINC UMLS NEDSS

Syndrome definition May be imprecise Sensitivity/Specificity tradeoff Expert guided vs. machine-guided?

Modeling the Data Establishing baseline Developing forecasting methods Detecting temporal signal Detecting spatial signal

Baseline Are data available to establish baseline? Periodic variations  Day  Month  Season  Year  Special days Variations in patient locations  Secular trends in population  Shifting referral patterns  Seasonal effects

Boston data Syndromic surveillance Influenza like illness Time and space

Forecasting

RESP SICK GI PAIN OTHER INJURY SKIN Components of ED volume

Forecasting

Principal Fourier component analysis 1 week.5 week 1 year 1/3 year

ARIMA modeling

Forecasting performance Overall ED Volume – Average Visits: 137 – ARMA(1,2) Model – Average Error: 7.8%

Forecasting

Forecasting performance Respiratory ED Volume – Average Visits: 17 – ARMA(1,1) Model – Average Error: 20.5%

GIS

Seasonal distributions

A curve fit to the cumulative distribution

A simulated outbreak

The cluster

Major issues Will this work at all??? Can we get better data? How do we tune for a particular attack? What to do without training data? What do we do with all the information? How do we set alarm thresholds? How do we protect patient privacy?

Will this work at all? A syndromic surveillance system operating in the metro DC area failed to pick up the 2001 anthrax mailings Is syndromic surveillance therefore a worthless technology? Need to consider the parameters of what will be detectable Do not ignore the monitoring role

Getting better data Approaches to standardizing data collection DEEDS Frontlines of Medicine project National Disease Epidemiologic Surveillance System, NEDSS

Tuning for a particular attack Attacks may have different “shapes” in the data Different methods may be more well suited to detect each particular shape If we use multiple methods at once, how do we deal with multiple testing?

Will this work at all? A syndromic surveillance system operating in the metro DC area failed to pick up the 2001 anthrax mailings Is syndromic surveillance therefore a worthless technology? Need to consider the parameters of what will be detectable Do not ignore the monitoring role

Getting better data Approaches to standardizing data collection DEEDS Frontlines of Medicine project National Disease Epidemiologic Surveillance System, NEDSS

No training data Need to rely on simulation Imprint an attack onto our data set, taking in to account regional peculiarities Artificial signal on probabilistic noise Artificial signal on real noise Real signal (from different data) on real noise

What do we do with all of this information? Signals from same data using multiple methods? Signals from overlapping geographical regions? Signals from remote geographical regions? Note: This highlights the important issue of interoperability and standards

Protecting patient privacy HIPAA and public health Mandatory reporting vs. syndromic surveillance The science of anonymization Minimum necessary data exchange Special issues with geocoded data